Average Co-Inventor Count = 7.33
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ligand Pharmaceuticals, Inc. (15 from 134 patents)
2. Novira Therapeutics, Inc. (3 from 44 patents)
18 patents:
1. 11773110 - Heterocycle amines and uses thereof
2. 11413274 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor
3. 11186593 - Heterocycle amines and uses thereof
4. 10736875 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor
5. 10710959 - Sulfide alkyl compounds for HBV treatment
6. 10604533 - Heterocycle amines and uses thereof
7. 10196351 - Sulfide alkyl compounds for HBV treatment
8. 10111859 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor
9. 10030034 - Heterocycle amines and uses thereof
10. 9622991 - Hematopoietic growth factor mimetic small molecule compounds and their uses
11. 9597332 - Sulfide alkyl compounds for HBV treatment
12. 9492430 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor
13. 9266874 - Heterocycle amines and uses thereof
14. 9144557 - Hematopoietic growth factor mimetic small molecule compounds and their uses
15. 8580811 - Androgen receptor modulator methods